Astec LifeSciences Limited has intimated the stock exchanges (BSE Limited and National Stock Exchange of India Limited) about an upcoming meeting of its Board of Directors. The meeting is scheduled to be held on Friday, 31st July, 2026.
The primary purpose of the board meeting is to consider and approve both the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2026 (Q1 FY27). The financial results will be reviewed by the company's Audit Committee prior to being presented to the board for approval.
The company has also made this intimation available on its official website at www.godrejastec.com.
The communication was signed by Tejashree Pradhan, Company Secretary & Compliance Officer (FCS 7167) of Astec LifeSciences Limited, on 21st July, 2026 at 16:23:58 IST.